Showing posts with label Twitter thread. Show all posts
Showing posts with label Twitter thread. Show all posts

Saturday, December 16, 2023

Mini-Study on ND vs NT Use of Masks

Abstract: 

An online survey was conducted to compare the rate of masks wearing behaviour between neurotypical and neurodiverse populations. A greater number of neurodiverse participants reported always wearing a mask.

Introduction:

The impetus for this study came from a post by Lucy (2023) who asked why "neuro atypical" people are so over represented in the Covid conscious community. I responded that it could be likely for the same reason that a higher percentage of Autistic people are 2SLGBTQIA+: "Autistic individuals may conform less to societal norms compared to non-autistic individuals" (Warrier et al, 2020). Lucy suggested a similar study be conducted on mask use. I set up a study to compare the neurotypical (NT) and neurodiverse (ND) self-reported mask-wearing behaviours.

Sunday, April 16, 2023

At What Point is Inaction a Form of Genocide??

This impressive and prescient thread worthy of saving is from Miles W. Griffis. He interweaves a speech from Vito Russo, AIDS activist, back and forth with current headlines on Covid-19 to show how easily we write-off a group of people when they become inconvenient:

Vito Russo's 1988 ACT UP speech "Why We Fight" has many parallels to the continuing Covid-19 pandemic currently causing 1,000+ deaths per week plus mass disability. Russo delivered "Why We Fight" during an ACT UP demonstration at the Department of Health and Human Services, D.C. on October 10, 1988. 

"My family thinks two things about my AIDS diagnosis. One, they think I'm going to die, and two, they think that my government is doing absolutely everything in their power to stop that, and they're wrong on both counts." 

"'A slow-moving glacier'" NIH's sluggish and often opaque efforts to study long Covid draw patient, expert ire." (Stat, March, 2022)

"If I'm dying from anything, I'm dying from racism."

"People of color less likely to receive Paxlovid and other Covid-19 treatments, according to CDC study." (CNN, October, 2022)